Faralimomab
Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1]
References
|
---|
|
Intracellular (initiation) | |
---|
|
Intracellular (reception) | |
---|
|
Extracellular | |
---|
|
---|
|
Chemokine | |
---|
|
CSF | | |
---|
| | |
---|
| | |
---|
| |
- Kinase inhibitors: Agerafenib
|
---|
| | |
---|
| | |
---|
|
---|
|
Interferon | |
- Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
- Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
- Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
- Decoy receptors: Bifarcept
|
---|
| | |
---|
| |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
|
Interleukin | |
---|
|
TGFβ | |
---|
|
TNF | |
---|
|
Others | |
---|
|
- See also: Peptide receptor modulators
- Growth factor receptor modulators
|